AFAS
PTPI

Acorn Financial Advisory Services’s Petros Pharmaceuticals PTPI Stock Holding History

Acorn Financial Advisory Services’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-201
Closed -$157K – 235
2021
Q2 		$157K Sell
201
-50
-20% -$40K 0.05% 231
2021
Q1 		$234K Hold
251
– – 0.09% 189
2020
Q4 		$276K Buy
+251
New +$236K 0.11% 182

Other funds holding PTPI

SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
NP
NorthRock Partners Minneapolis, Minnesota $6.2B AUM 15.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acorn Financial Advisory Services's PTPI Position: Q3 2021 in Review

Acorn Financial Advisory Services sold out of Petros Pharmaceuticals (PTPI) in Q3 2021, closing a stake of 201 shares — an estimated $157K sold.

Acorn Financial Advisory Services first reported a position in PTPI in Q4 2020 and held it in 3 quarters. The position peaked at $276K in Q4 2020. 16 funds tracked by Wall St. Rank hold PTPI as of Q3 2021.

  • Acorn Financial Advisory Services reported no remaining Petros Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Acorn Financial Advisory Services sold 201 Petros Pharmaceuticals shares in Q3 2021, an estimated $157K.
  • Acorn Financial Advisory Services first reported a position in Petros Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Acorn Financial Advisory Services's Petros Pharmaceuticals position peaked at $276K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q3 2021.

Based on Acorn Financial Advisory Services's 13F filing for Q3 2021, filed 15 Nov 2021.